OB PPH Flashcards
1
Q
Contraindication to Methergine
A
HTN
2
Q
Repeat interval of Methergine
Total repeat doses
A
2 hours
(In practice most will repeat after 15 minutes)
No max amount
3
Q
Hemabate
- Dosage
- Repeat interval
- Total repeat doses
- Contraindication
- Class of drug
A
- 250 micrograms
- 15 mins
- 8 doses
- Asthma
- PGf alpha
4
Q
Dose of cytotec for PPH
A
1 mg
5
Q
PRBC
- Volume
- Effect on hgb
- Effect on hct
A
- 250 cc
- Hgb inc by 1
- Hct incr 3%
6
Q
Plt
- Volume
- Content
- Effect
A
- 50cc
- 50 mil plt
- Rises 5-10,000
7
Q
FFP
- Volume
- Content
- Effect
A
- 250cc
- 200mg Fib, fac V, VIII, antithrombin III
- Until fibrinogen >100, or normal PT
8
Q
Cryoprecipitate
- Volume
- Content
- Effect
- Dose
A
- 25 cc
- 200 mg Fib, fac VIII, XIII, von Willebrand
factor - Until Fib >100, normal PT
- 1u/5-10 kg wt
9
Q
Rate of crystalloid repletion per EBL
A
3cc crystalloid/1cc EBL
10
Q
Definition of Massive Transfusion Protocol
A
replacement of >50% of blood volume in 12-24 hours
11
Q
O’Leary Stitch
A
Uterine artery ligation
12
Q
B-lynch stitch placement
A
3cm below incision
13
Q
Warfarin
- Mechanism of Action
- Placental Transfer
- Teratogenic
- Labs for monitoring
- Clinical Aim
- Dose
- Antidote
- Side Effects
- Half-life
A
- Factors 2, 7, 9, 10
- Yes
- Yes
- PT, INR
- 2-3.0
- Variable
- Vit K
- Fetal bleeding, Fetal Coumadin Synd (1TM- stippled epiphyses, limb+nasal hypoplasia, 2TM- optic atrophy + microcephaly)
- 4 hours
14
Q
Heparin
- Mechanism of Action
- Placental Transfer
- Teratogenic
- Labs for monitoring
- Clinical Aim
- Dose
- Antidote
- Side Effects
- Half-life
A
- Co-factor for Antithrombin Xa
Increases inhibition of thrombin & Factor Xa - No
- No
- PTT
- 1.5-2.0
- 1000 u/hr or 6000 u Q6 hr (proph 5000 u BID)
- Protamine sulfate (1mg/100u Heparin) Max 15mg/15 min
- Maternal thrombocytopenia , osteoporosis (both w/ long term use)
- 1.5 hrs
15
Q
LMWH (Enoxaparin)
- MOA
- Monitoring
- Advantages
- Disadvantages
- Placental Transfer
A
- Inhibits factor Xa (better than reg heparin)
- only w/ therapeutic anticoag- anti-Xa Q4-6 wks
(obtain 4 hrs after dosing) - Longer half life (once or twice daily dosing), dec risk of thrombocytopenia, osteoporosis, post-op bleeding
- cost, inc risk of epidural hematoma (wait >12 hrs w/ prophylactic dosing for epidural and > 24 hrs w/ therapeutic dosing), contraind in preg w/ prosthetic valves